Serum Lipid and Protein Changes in Healthy Dyslipidemic Subjects Given a Selective Inhibitor of p70 S6 Kinase-1
Author:
Affiliation:
1. Eli Lilly and Company; Indianapolis IN USA
Funder
Eli Lilly and Company
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Reference28 articles.
1. mTOR couples cellular nutrient sensing to organismal metabolic homeostasis;Howell;Trends Endocrinol Metab,2011
2. Akt deficiency impairs normal cell prolqueriferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner;Skeen;Cancer Cell,2006
3. A phase Ib trial of LY2584702 tosylate, a p70 S6 inhibitor, in combination with erlotinib or everolimus in patients with solid tumours;Hollebecque;Eur J Cancer,2014
4. A phase I trial of LY2584702 tosylate, a p70 S6 kinase inhibitor, in patients with advanced solid tumours;Tolcher;Eur J Cancer,2014
5. A phase I study of a p70S6 kinase inhibitor (LY2584702) in patients (pts) with solid tumors;Doi;Cancer Res,2013
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Beyond controlling cell size: functional analyses of S6K in tumorigenesis;Cell Death & Disease;2022-07-25
2. Research Progress of 70 kDa Ribosomal Protein S6 Kinase (P70S6K) Inhibitors as Effective Therapeutic Tools for Obesity, Type II Diabetes and Cancer;Current Medicinal Chemistry;2020-08-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3